MyCelx Tech. Corp. MyCelx Tech. Cp-MYXR - Director Dealing

Mycelx Technologies

16/02/2026 10:46

RNS Number : 1807T

MyCelx Technologies Corporation

16 February 2026

 

16 February 2026

 

MYCELX Technologies Corporation

("MYCELX" or the "Company" (AIM: MYX)

 

 

Director Dealing

 

The Company announces that it was notified on 13 February 2026 by Gareth Kaminski-Cook, Non-executive Chairman of the Board of Directors of the Company, that:

 

-     on 11 February 2026, he purchased 2,350 common shares in the Company of US$0.025 each ("Common Shares"), at a price of £0.47 per Common Share; and

 

-     on 12 February 2026, he purchased 2,100 common shares in the Company of US$0.025 each ("Common Shares"), at a price of £0.46 per Common Share.

 

Following these transactions, Mr. Kaminski-Cook holds 4,450 Common Shares representing 0.02 per cent of the total issued capital of the Company.

 

 

For further information please contact:

 

MYCELX Technologies Corporation
Connie Mixon, CEO
Kim Slayton, CFO
Tel: +1 888 306 6843
Cavendish Capital Markets Limited (Nominated Adviser and Sole Broker)
Giles Balleny /Callum Davidson/Elysia Bough (Corporate Finance)
Harriet Ward (Corporate Broking)
Jasper Berry / Michael Johnson (Sales)
Tel: +44 20 7220 0500

 

Notification of transactions of persons discharging managerial responsibility or connected persons

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Gareth Kaminski-Cook
2
Reason for the notification
a)
Position/status
Non-Executive Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
MYCELX Technologies Corporation
b)
LEI
213800UJZINIK2VD1G48
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Common shares of US$0.025
ISIN: US62847T2024
b)
Nature of the transaction
Purchase of Common Shares in GBP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.47
2,350
d)
Aggregated information
- Aggregated volume
- Price
n/a
n/a
e)
Date of the transaction
11/02/2026
f)
Place of the transaction
London Stock Exchange(AIM)

 

 

 

 

Notification of transactions of persons discharging managerial responsibility or connected persons

 

1
Details of the person discharging managerial responsibilities / person closely associated
a)
Name
Gareth Kaminski-Cook
2
Reason for the notification
a)
Position/status
Non-Executive Chairman
b)
Initial notification /Amendment
Initial notification
3
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor
a)
Name
MYCELX Technologies Corporation
b)
LEI
213800UJZINIK2VD1G48
4
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted
a)
Description of the financial instrument, type of instrument
Common shares of US$0.025
ISIN: US62847T2024
b)
Nature of the transaction
Purchase of Common Shares in GBP
c)
Price(s) and volume(s)
Price(s)
Volume(s)
£0.46
2,100
d)
Aggregated information
- Aggregated volume
- Price
n/a
n/a
e)
Date of the transaction
12/02/2026
f)
Place of the transaction
London Stock Exchange(AIM)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 
  END

 

 
DSHFLFVIFEIRLIR